Manufacturer record
Actinova Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Actinova Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between August 2021 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ADH5045, Ceftriaxone for Injection IP (exp Jul 2027). ALIGARH, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conforms to I.P. in the respect of content of ceftriaxone. Listed in the September 2026 alert.
Records by type
4 records linked to Actinova Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ceftriaxone for Injection IP | Batch ADH5045Mfg Aug 2025 · Exp Jul 2027 | The sample does not conforms to I.P. in the respect of content of ceftriaxone.Other | ALIGARH, Uttar PradeshState lab | Sep 2026 |
| Levocetirizine Dihydrochloride Tablets I.P | Batch ATGI4259Mfg Sep 2024 · Exp Aug 2026 | Content of Levocetirizine DihydrochlorideOther | SDTL, PunjabState lab | Mar 2026 |
| CALCID | Batch ALGE4061Mfg May 2024 · Exp Apr 2026 | DescriptionDescription | ChhattisgarhState lab | Mar 2026 |
| Ranitidine Tablet 150 mg (ACITEK-150) | Batch AT1A020Mfg Jan 2021 · Exp Dec 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.